These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9635831)

  • 1. Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.
    Sørlie T; Martel-Planche G; Hainaut P; Lewalter J; Holm R; Børresen-Dale AL; Montesano R
    Br J Cancer; 1998 May; 77(10):1573-9. PubMed ID: 9635831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.
    Droller MJ
    J Urol; 1998 Aug; 160(2):618. PubMed ID: 9679939
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.
    Yasunaga Y; Nakanishi H; Naka N; Miki T; Tsujimura T; Itatani H; Okuyama A; Aozasa K
    Lab Invest; 1997 Dec; 77(6):677-84. PubMed ID: 9426406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in bladder tumors from arylamine-exposed workers.
    Taylor JA; Li Y; He M; Mason T; Mettlin C; Vogler WJ; Maygarden S; Liu E
    Cancer Res; 1996 Jan; 56(2):294-8. PubMed ID: 8542583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
    Yu D; Liu F; Liang Z
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors.
    Esteve A; Sørlie T; Martel-Planche G; Hollstein M; Kusters I; Lewalter J; Vineis P; Stephan-Odenthal M; Montesano R
    J Occup Environ Med; 1995 Jan; 37(1):59-68. PubMed ID: 7620944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Chen T; Murai T; Mori S; Morimura K; Oohara T; Makino S; Tatematsu M; Wanibuchi H; Fukushima S
    Carcinogenesis; 1997 Oct; 18(10):1877-82. PubMed ID: 9363994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
    Malkowicz SB; Tomaszewski JE; Linnenbach AJ; Cangiano TA; Maruta Y; McGarvey TW
    Oncogene; 1996 Nov; 13(9):1831-7. PubMed ID: 8934528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
    Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
    Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine.
    Nishikawa T; Salim EI; Morimura K; Kaneko M; Ogawa M; Kinoshita A; Osugi H; Kinoshita H; Fukushima S
    Cancer Lett; 2003 May; 194(1):45-54. PubMed ID: 12706858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p21WAF1/CIP1 in primary bladder tumors.
    Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
    Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific aromatic amines as occupational bladder carcinogens.
    Clayson DB
    Natl Cancer Inst Monogr; 1981 Dec; (58):15-9. PubMed ID: 7341971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
    Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
    Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.